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GENERAL INTRODUCTION

Fat is a necessary nutrient in the diet of all humans. Fat
supplies essential fatty acids and fat soluble vitamins. The use of fat
versus glucose in the clinical setting has some definite advantages.
Less carbon dioxide is produced when fat is oxidized for fuel verses
glucose, which is especially important when trying to wean·· respirator
dependent patients. Because fat is isotonic, it can be infused
intravenously to provide a patient with a calorically dense source of
energy. In comparison, a glucose solution is hypertonic. Glucose
solutions above 5 % can cause phlebitis at peripheral infusion sites.
Its intravenous use in lieu of glucose has been shown to promote
euglycemia in diabetic patients.
Dietary fats are composed primarily of long-chain triglycerides
(fatty acid chain length � 14 carbons, LCT). In addition to the
aforementioned clinical advantages, the use of LCT have been
associated with decreased incidence of fatty liver. However, the
clinical use of LCT in intravenous nutrition have been reported to have
some undesirable metabolic consequences. They have been shown to
decrease bacterial resistance, increase plasma triglycerides and plasma
1

cholesterol and during long-term use induce hepatic dysfunction. In
addition to their undesirable metabolic effects, LCT are insoluble in
water and, subsequently, are difficult to incorporate into intravenous
solutions.
Due to the undesirable attributes associated with LCT use,
medium-chain triglycerides (fatty acid chain length of 6-12 carbons,
MCT) have been investigated as a fat source. Because MCT do not
require bile acids for absorption, they make an excellent source of lipid
when given at low doses for those patients who have problems
digesting and absorbing LCT. MCT use has been found to be useful in
ketogenic diets for treatment of childhood epilepsy as they induce
ketonuria more easily than other dietary fats. MCT are rapidly
metabolized and used for energy. However, high doses of MCT have
been associated with metabolic abnormalities, such as abnormalities in
central nervous syster:n function.
Because of the problems related to the use of LCT and MCT,
new lipid alternatives have been investigated. One lipid alternative
studied has been the short-chain triglycerides (fatty acid chain length
of 2-4 carbons, SCT) and short-chain fatty acids- (fatty acid chain
length of 2-4 carbons, SCFA). The SCFA, acetate, propionate, and

2

butyrate, are normally produced in the colon from the fermentation of
nondigestible carbohydrate by the colonic bacteria. They are a
preferred energy source of the cells in the colon. SCT are easily
soluble in water and provide for easy mixing into water-based
intravenous solutions. During acute administration (7- 10 days), they
have proved beneficial. They are cleared from the plasma quickly and
metabolized completely for energy. Enteral and intracolonic infusions
of SCT and SCFA have been reported to increased nitrogen balance in
patients as well as decreased atrophy of the intestinal mucosa. The
intravenous use of SCT has been shown to be safe in animals. The
safety and effectiveness of SCT in intravenous administration in
humans has yet to be determined. SCT do not, however, obviate the
use of LCT as they do not provide the essential fatty acids. Recent
investigation has indicated that parenteral/enteral use of SCT for up to
seven days has desirable effects on ketogenesis, protein metabolism,
and the intestinal mucosa. However, their effectiveness in long-term
use is not known at this time.
The objectives of this study are to determine the effects of an
long-term (30 day) oral diet containing SCT on the intestinal mucosa,
plasma substrates, and growth and development in rats. The effects
3

on the intestine were measured in the jejunum and the colon
biochemically and histologically. Biochemical indices included DNA,
RNA, and protein. Histological measures included villus height in the
jejunum and crypt depth in the colon. The plasma substrate
concentrations measured were free fatty acid, total ketone body,
pyruvate, lactate, triglyceride, and glucose. Growth and development
will be evaluated by comparing body weight (growth), body
composition (% water, % protein, % fat, and % ash), and adipocyte
cell size and number in the epididymal, inguinal, and perirenal fat
depots.

4

EXPLANATION OF THESIS FORMAT

This thesis contains a general introduction and two separate
papers to be submitted for publication. All of the data from the two
papers came from one experimental study that I performed at the
University of Tennessee, Knoxville under the direction of my major
professor, Dr. James Bailey. As needed, some data is duplicated in
both studies for clarity.

5

Part 1: Triacetin feeding for 30 days increased intestinal
cellular proliferation without adversely affecting
plasma substrate concentrations

ABSTRACT

Diets containing either the short-chain triglyceride (SCT)
triacetin or long-chain triglyceride (LCT) were fed to rats to determine
the effects on intestinal mucosa cells and plasma substrates. Male
Sprague Dawley rats were given one of three diets, a control diet
containing 5% LCT (by calories) or one of two experimental diets that
were 30% lipid (by calories). The lipid component of-the LCT group
was 100% LCT while that of the SCT group was 95% SCT/ 5% LCT.
Plasma lactate, glucose, and total ketone body concentrations were
unaffected by diet. Compared to the LCT and control groups, plasma
pyruvate and free fatty acid concentrations were decreased in animals
fed .SCT. In contrast, plasma triglyceride concentrations were
elevated in the SCT group compared to other groups. Intestinal
biochemical �.easures included total DNA, RNA, protein and the
protein:DNA ratio. Histological indices measured were villus height in
the jejunum and crypt depth in the colon. Mucosal protein
concentration was unaffected in the jejunum and colon. Jejunal RNA
was significantly decreased in the SCT group compared to other
groups. SCT feeding significantly increased the DNA content in the
7

jejunum and colon thereby lowering the protein:DNA ratio, indicating
smaller, more numerous cells. And jejunal villus height and colonic
crypt depth were unaffected by diet. Provision of a balanced diet
containing 28.5% of the total calories as the SCT triacetin had no
adverse effects on metabolic substrates and resulted in smaller and
more numerous mucosal cells in the jejunum and colon. These data
indicate that the S�T triacetin could provide benefit in the
maintenance of gut integrity and in the treatment of certain intestinal
disorders.

8
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INTRODUCTION

Short-chain fatty acids (SCFA) are produced in the colon by
bacterial fermentation of undigestible carbohydrates, such as
cellulose, pectins, and hemicellulose ( 1). The primary SCFA
produced are acetate, propionate, and butyrate. They are found in the
human colon in the molar ratios of 60: 24: 16 and account for about
7% of total body energy maintenance requirements (2). _9ther
.
reports suggest ranges of molar ratios of acetate, propionate, and
butyrate of 75: 15: 10 to 40: 30: 20 (3). More than 95% of the SCFA
that are produced in the colon are readily absorbed (1 ). Once
absorbed, they are preferred oxidative fuels of the colonocytes (2).
They are even preferred over glucose and glutamine (4) and account
for 60-70% of the energy requirements of the colonocytes (5).
Therefore, it can been seen that the SCFA are an important part of the
nutriture of the colonic mucosa.
SCFA in the form of triglycerides, short-chain triglycerides
(SCT), are water soluble and can easily be mixed into water-based
parenteral solutions. Because of their size, they can bypass the
carnitine acyltransferase system that is required for metabolizing the
10

longer chain fatty acids normally found in food. They are cleared from
the plasma quickly. In the intestinal epithelium, the primary metabolic
pathway is complete oxidation to CO 2 (6). In vivo and in vitro, their
use increases blood flow to the large bowel (7,8). Furthermore,
they increase sodium and water absorption in the large bowel
(9,10,11).
Recent research has focused on the trophic effects of SCT and
SCFA in the small and large bowel. When given as intracolonic
infusions (12,13) and in in vitro studies (14), SCFA stimulate
epithelial cellular proliferation in the colon. Other evidence suggests
that the acute use (7-10 days) of intravenous SCT, in particular
triacetin, could be beneficial in stimulating cellular proliferation in the
colon and thereby decreasing intestinal atrophy associated with the
use of TPN and trauma (15,16).
SCT and SCFA have been shown to be helpful in several
disease states. SCFA irrigation in patients with diversion colitis
reversed symptoms (17). lntracolonic infusions of SCFA indicated
trophic and vasodilatory effects on the colon of patients undergoing
Hartmann's procedure (7). In rats with experimentally induced short
bowel syndrome, elemental enteral diets with SCT increased intestinal
11

adaptation when compared with medium-chain triglycerides (18).
Infusions of SCFA promoted the healing of anastomosis in rats
(19).

Little is known about the effects of SCT on the intestinal
mucosal cells in a non-trauma or non-diseased model (20) or about
the safety of the compound when administered longer term. This
study was carried out to assess the metabolic effects of the SCT,
triacetin, on the intestinal mucosal cells and plasma substrates in rats.

12

MATERIALS AND METHODS

Animal care and conduct of experiments were approved by the
University of Tennessee Animal Care and Use Committee, which
follows NIH guidelines on the humane use of laboratory animals.
Twenty-four male Sprague Dawley rats weighing 100 ± 10 g were
obtained from Harlan (Indianapolis, IN). Rats were housed in
individual plastic metabolic cages with ad libitum access to food and
water. After an adaptation period of four days, the rats were
randomly placed into one of three dietary groups, with eight animals
per group. Animals received diets that varied in fat composition.
Table 1 shows the composition of the control and experimental diets.
The diets contained either long-chain triglyceride (LCT) in the form of
corn oil and/or SCT in the form of triacetin (Sigma, St. Louis, MO).
All diets contained 22% (% calories) protein. Weight percentages of
vitamins, minerals, and fiber were 1.0%, 3. 5%, and 5.0%
respectively to meet American Institute of Nutrition standards.
Animals received one of three diets. The control diet (5 % fat by
calories) contained lipid that was 100% LCT. The two experimental
diets were 30% lipid (by calories). The lipid component of the two
13

Table 1. Diet composition
SCT

LCT

Control
wt %

% kcal

wt %

% kcal

wt %

% kcal

casein

19.2

20.6

22.4

20.6

21.0

20.5

methionine

0.3

0.3

0.4

0.4

0.3

0.4

cornstarch

13.7

15.0

10.6

10.0

9.9

10.0

sucrose

55.0

59.0

42.5

39.0

39.4

38.0

fiber

5.0

corn oil 1
(LCT)

2.1

5.0

5.3

14.4

5.0

30.0

triacetin
(SCT)

0.7

2.0

19.0

28.0

Mineral Mix2

3.5

3.5

3.5

Vitamin
Mix 3

1.0

1.0

1.0

Choline
bitartrate

0.2

0.2

0.2

Total

100.0

100.0

99.7

99.8

100.0

Fatty acid composition corn oil - palmitate (11.5%), stearate (2.2%), oleate
(26.6%), linoleate (58.7%), linolenate (0.8%), other (0.2%)
2
AIN Mineral Mixture 76 (per 1 kg): calcium phosphate dibasic 500 g, sodium
chloride 74 g, potassium citrate monohydrate 220 g, potassium sulfate 52 g;
magnesium oxide 24 g, manganous carbonate 3.5 g, ferric citrate 6 g, zinc
carbonate 1.6 g, cupric carbonate 0.3 g, potassium iodate 0.01 g, sodium selenite
0.01 g, chromium potassium sulfate 0.55 g, sucrose 118 g
3
AIN Vitamin Mixture 76 (per 1 kg): thiamine hydrochloride 600 mg, riboflavin 600
mg, pyridoxine hydrochloride 700 mg, nicotinic acid 3 g, 0-calcium pantothenate
1.6 g, folic acid 200 mg, 0-biotin 20 mg, cyanocobalamin 1 mg, retinyl palmitate
(250,000 IU/g) 1.6 g, DL-alpha-tocopherol acetate (250 IU/g) 20 g, cholecalciferol
(400000 IU/g) 250 mg, menaquinone 5 mg, sucrose 972.9 g
1

14
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experimental diets was either 100% LCT (LCT group) or 95% SCT/
5% LCT (SCT group). The LCT in the third diet was incorporated to
prevent essential fatty acid deficiency. All animals received diets for
30 days. Food intake was measured daily until the end of the
experiment. Body weights were determined at day O and for every 5
days thereafter until day 30.

On day 30, animals were euthanized by

decapitation.
Blood was collected into Vacutainer (Becton Dickinson,
Rutherford, NJ) tubes containing EDTA and centrifuged at 1740 x g
for 15 minutes at 4 ° C. Plasma glucose and plasma triglycerides (TG)
were determined using Sigma kit numbers 510-A and 336-10
respectively (Sigma, St. Louis, MO). Total plasma ketone bodies
(21 ), defined as beta-hydroxybutyrate plus acetoacetate, plasma
free fatty acids (FFA) (22), and plasma lactate and pyruvate (23)
were measured.
The small intestine was dissected from the ligament of Treitz to
the cecum. The colon was dissected distal to the cecum to the anus.
Each was placed under the tension of a 10 g weight. A jejunum
segment was taken from the first 10 cm of the small bowel.
Similarly, a colon segment was taken from the first 10 cm of the large
15

bowel. Segments were flushed with cold saline, stripped of excess
fat, and weighed. Intestinal segments were inverted and scraped with
a glass slide for the removal of the mucosal cells. The mucosal cells
were analyzed for DNA, RNA, and protein content by the modified
methods of Burton (24), Fleck and Begg (25), and Lowry (26),
respectively. The protein-DNA ratio for each group was calculated as
an index of cell size (mg protein/10 cm divided by mg DNA/1.Q cm).
A 2 cm segment from the jejunum and the colon were also
removed and fixed in neutral buffered formalin. The segments were
embedded in Paraplast Tissue Embedding Medium (Oxford Labware,
St. Louis, MO) using a Tissue - Tek Dispensing Console, Thermal
Console, and Crio Console (Miles, Inc., Elkhart, IN). Ten micron cross
sections were stained with hematoxylin (27) and eosin using a
modified procedure (28). Sections were analyzed using light
microscopy to determ�ne villus height in the jejunum and crypt depth
in the colon.
All data was analyzed using analysis of variance (ANOVA) with
the Statistical Analysis Software (SAS, Cary, NC) system to
determine significant differences among groups due to diet.
Significance was considered to be p < 0.05. When a significant
16

difference was observed, Duncan's Multiple Range Test was used to
further analyze the differences.

17

RESULTS

No overt adverse effects of any diet were observed during the
30 days of experimental study. Table 2 shows the effect of dietary
lipid composition on body mass and food consumption. Body mass
was not significantly different at the beginning of the study period.
However, by day 30, the rats in the LCT group weighed significantly
more than the animals in the other groups. Caloric consumption per
day for each week of study was calculated from the daily intake
records (Table 2). Food consumption was not significantly different
among groups at week 1. During week 2, both LCT and SCT groups
ate significantly more than the control group. During weeks 3 and 4,
only the LCT group ate significantly more than the animals in the
control group. Food consumption was not significantly different
between LCT and SCT groups throughout the study period.
The effects of dietary lipid composition on plasma substrates
are shown in Table 3. There were no significant differences in
lactate, ketone body, and glucose concentrations among groups.
Plasma lactate concentration in the SCT group (33.0 ± 7.8 µM) was
significantly lower than the LCT group (74.5 ± 2.8 µM). Plasma FFA
18

Table 2. Body mass and food consumption of rats fed short- or long-chain triglyceride for 30 days

�
(0

Food Consumption
( Kcal/di

Body Mass
(g J

Group
Day 0

Day 30

Control

1 2 5.8 :t 2.3

305 . 1 :t 8.5

LCT

1 1 5 .3 :t 1 .0

338.5 :t 4 . 5

SCT

1 3 1 .7 :t 1 .7

304 .0 :t 6.4

.

Week 1

Week 2

Week 3

Week 4

64 . 1 :t 3.0

68.3 :t 3.o·

75.4 :t 3.9

73.6 :1: 4 . 7

63.8 ± 3 . 9

77.0 :t 4. 1

83.7 :1: 3.a··

8 1 . 9 :1: 5 .o· ·

65 . 6 :t 3 . 9

77.8 ± 1 .5

79.3 ± 5 . 6

77.2 ± 4 .8

8 animals per group; all values expressed as means :t SEM
• significantly different from other groups, p < 0.05
•• significantly different from control, p < 0 .05

Table 3. Plasma substrate c oncentrations of rats fed short- or long- chain trlglycerlde for 30 days
Group

"'0

FFA

PYR

(mM)

(µM)

LAC

TK B

TG

GLU

fmM) '

(µM)

fmg/dl)

fmg/dl)

Control

0.89 :t 0.07

67.6 :t 6.6

2 .63 :t 0.24

47.8 :t 4.9

1 85 :t 1 0.9

1 4 8 :t 4 . 7

LCT

1 .0 1 :t 0.04

74.5 :t 2 .8

1 . 96 :t 0. 1 1

50.6 :t 8.0

1 87 :1: 9.2

1 5 7 :1: 2 .9

SCT

0.60 :t 0.04 •

33.0 :t 7 . 8 . .

2 .36 :t 0 . 1 8

6 6 .0 :t 4.7

2 2 5 :I: 1 2 . 1 ·

1 59 :1: 6.3

FfA ... free fauv acids; PYR • pyruvate; LAC • lactate; TKB • total ketone bodies; TG • triglycerides; GLU = glucose
8 animals par group; all values expressed as means ::I: SEM
• significantly different from other groups, p < 0.06
• • significantly different from LCT. p< 0.05

were significantly lower in the SCT group (0. 50 ± 0.04 mM)
compared to the LCT ( 1. 0 1 ± 0.04 mM) and control (0.89 ± 0.07
mM) groups. Additionally, the plasma triglyceride concentration in the
SCT group was significantly higher in the SCT group compared to the
LCT and control groups (225 ± 12. 1 mg/dl vs 187 ± 9. 2 mg/dl and
18 5 ± 10.9 mg/dl, respectively).
Feeding the SCT diet for 30 days was associated with a
significant increase in DNA content of the jejunal and colonic mucosa
(Figure 1). In the jejunum, animals consuming the SCT diet had a
significantly higher DNA content than did the LCT group (0. 5 5 ±
0.07 mg/ 10 cm compared to 0. 2 1 ± 0.02 mg/ 10 cm). The DNA
content in the control group (0.43 ± 0.06 mg/ 10 cm) was also
greater than that in the LCT group. There were no significant
differences in the DNA content of the jejunum between the SCT and
control groups .. . In the colon, the DNA content was the greatest in the
SCT group (0. 32 ± 0.04 mg/ 10 cm compared to LCT 0. 2 1 ± 0.02
mg/ 10 cm and control 0. 19 ± 0.03 mg/ 10 cm).
The only significant effect of diet on RNA content was
observed in the jejunum (Figure 2). Animals in the SCT group had
significantly less RNA per 10 cm than the other two groups. Jejunal
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Figure 1. Jejunal and colonic DNA concentrations (µg/10 cm) of rats
fed short- or long-chain triglyceride for 30 days
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Figure 2. Jejunal and colonic RNA concentrations (µg/ 1 0 cm) of rats
fed short- or long-chain triglyceride for 30 days
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RNA content was as follows: SCT, 0. 53 ± 0.03 mg/ 10 cm; LCT,
1.06 ± 0.07 mg/ 10 cm; and control, 0.89 ± 0.08 mg/ 10 cm. No
differences in RNA content of the colonic mucosa were observed.
Similarly, no significant differences were noted in protein content of
the jejunal or colonic mucosa (Figure 3).
For the jejunal mucosa, the protein: DNA ratio was significantly
different among all groups (Figure 4). The smallest ratio was seen in
the SCT group (29. 5 ± 4. 6) with the next two highest values in the
control group (47.4 ± 5. 2) and LCT �group (76. 2 ± 5 . 5). In the colon,
there were no significant differences among the protein: DNA ratios
(Figure 4). However, the smallest value was once again in the SCT
group (47.0 ± 8. 7). The control group was second smallest (57. 4 ±
4.9), and the LCT group had the highest protein: DNA ratio (60. 6 ±
4. 2).
Differences in crypt depth in the colonic segments and in villus
height in the jejunal segments are shown in Table 4. No significant
differences in crypt depth were observed. Mean values for crypt
depth for control, LCT, and SCT are 0. 24 ± 0.0 1 µm, 0. 2 1 ± 0.0 1
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Figure 3. Jejunal and colonic protein concentrations (µg/1 0 cm) of rats
fed short- or long-chain triglyceride for 30 days
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Table 4. Colonic crypt depth and jejunal villus height of rats fed short
or long-chain triglyceride for 30 days
Crypt Depth

Villus Height

(µm)

(µm)

Control

0. 24 ± 0 . 0 1

0.56 ± 0 .03

LCT

0.21 ± 0.01

0.54 ± 0.05

SCT

0 . 2 1 ± 0.02

0 .49 ± 0 .03

Group

8 animals per group; all values expressed as means ± SEM
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pm, and 0 . 2 1 ± 0.02 pm, respectively. Mean villus height for control
(0. 56 ± 0 . 03 pm) , LCT (0. 54 ± 0. 05 pm) , and SCT (0. 49 ± 0. 03

pm) groups was unaffected by diet.
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DISCUSSION

The results of the present study indicate that a 30 day oral diet
with 28.5 % of the total calories supplied as the SCT triacetin
produce no overt toxic effects in the rat while stimulating cellular
proliferation in the jejunum and the colon. The elevated DNA
concentration of the jejunal and the colonic mucosal cells observed in
the animals fed triacetin demonstrat� an increase in the number of
cells in these areas as the DNA content of eukaryotic cells is relatively
constant. These results agree with previous studies. When used
enterally, parenterally, and as intracolonic infusions, SCFA and SCT
have been shown to have a trophic effect on the colonocytes and on
the jejunal mucosaI cells of rats (7, 12-16). The protein: DNA ratio is
commonly used as an index of cell size. Mucosal protein content was
not significantly different among treatment groups. However, DNA
concentration was significantly greater in animals fed SCT.
Subsequently, the protein: DNA ratio was significantly lowered in the
animals fed triacetin. The lower protein: DNA ratio in the SCT group
would indicate smaller, more numerous cells in the jejunum and colon.
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The mechanism for this increase is cellular proliferation is thought to
be the increased availability of the SCFA acetate to the intestinal
mucosa, particularly in the colon. Digestion of Triacetin is initiated in
the stomach by gastric lipase (29). The SCFA are absorbed in the
stomach and primarily in the jejunum into the portal system in the
form of FFA (6). Once in the portal system, they are delivered to the
liver where they may be used for the synthesis of long-chain fatty
acids and LCT, glutamine, and the ketone bodies acetoacetate and
beta-hydroxybutyrate (30). As a majority of the SCT are absorbed
in the jejunum, they are available to the intestinal mucosa cells for use
as oxidative fuel. In fact, the catabolism of SCFA by the intestinal
epithelium to CO2 is a predominant pathway (6). This could explain
the increased proliferation seen in the jejunum of rats consuming the
SCT diet versus those consuming the LCT diet.
Although proliferation increased in the jejunum and colon with
SCT feeding, crypt depth and villus height were unaffected by diet.
Increased proliferation may not always translate into an increase in the
crypt depth or villus height. The cells in the SCT group were smaller
and more numerous as previously mentioned. An increased
proliferation with smaller cells could result in no change in size of the
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total segment (i.e. crypt or villus). Measurements of the size of the
crypt and villus most likely correspond to total protein content of the
segment. Like crypt depth and villus height, the protein content in the
jejunum and colon was also found to be unaffected by diet. The
trends in villus height in the jejunum mimick those seen in protein
content in the jejunum with both being largest in the control group
and smallest in the SCT group. The trends for crypt depth and protein
content in the colon are also similar with the SCT and- LCT groups
being the smallest in crypt depth and the control group having the
largest crypt depth.
The changes in RNA concentration seen in the jejunum and
colon reflect changes seen in protein content. The amount of RNA
present_presumable would influence the amount of protein
synthesized. In the colon, the amount of RNA increases from the
control group t_<;> the SCT group. This trend is also present in protein
concentration of the colon with the control group having the least
protein and the SCT group containing the most protein. This trend
can also be observed in the jejunum. For the most part, decreasing
amounts of ·RNA in the jejunum correspond to decreasing amount of
protien.
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It is important to note that the provision of the SCT diet did not
have a significant anorexic effect when compared to the control and
LCT groups. Intake for the four weeks of study was not significantly
different between the SCT and LCT groups. The LCT animals actually
consumed more Kcal/d for all four weeks when compared to the
control animals. During weeks 1 and 2, the caloric consumption of
the LCT and SCT groups were almost identical. However, during
weeks 3 and 4, the caloric consumption of animals consuming the
SCT diet tended to be lower than those consuming 30% LCT. This
difference may be due to the unpalatability of the SCT diet. The
differences in food consumption is reflected in ending body mass with
the LCT group weighing more on the average than the other two
groups.
Thirty day feeding of SCT did not have any overt adverse
effects. Plasma lactate concentrations were unaffected while the
pyruvate concentrations were decreased in the SCT group compared
to the LCT group. This decrease in pyruvate concentrations could be
explained in two possible ways. The increased availability of acetate
with SCT feeding could increase acetyl-CoA levels, thereby increasing
citrate synthesis via the citric acid cycle. Acetyl-CoA is a known
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inhibitor of pyruvate kinase, and citrate is a known inhibitor of
phosphofructokinase (31). Inhibition of both enzymes could
contribute to a decreased pyruvate concentration. Plasma glucose
and total ketone body concentrations were unaffected. Increased
availability of the SCFA acetate have been previously shown to
increase ketone body production by the liver (32). In the study,
triacetin was infused as the only source of calories for three hours to
dogs at 70% above the resting energy expenditure. The reason for
the lack of increase in ketone body concentration in the present study
is due to a much lower amount of SCT being administered to the
animals (28.5% of total calories). When incorporated into a balanced
diet, the lack of increase in ketone body concentration is observed.
Another factor contributing to the lack of increase in ketone bodies
may be due to a large uptake of acetate by the intestine and a
possible increase in LGT synthesis from acetate. Other observed
effects on plasma substrates included a decrease in the plasma FFA
concentration. As the SCFA acetate is absorbed in the FFA form (6),
the plasma FFA concentration would be expected to increase. Plasma
triglyceride concentration was significantly increased in the group
consuming the SCT diet. This increase could be due to increased
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synthesis of LCT from acetate. Previous studies of Zucker rats
consuming diets containing MCT reported elevated triglyceride
concentrations (33) compared to animals receiving equivalent diets
of LCT. The fatty acid synthase activity in these animals was also
elevated, suggesting increased lipogenesis. In addition, the adipose
tissue lipoprotein lipase activity was depressed in animals receiving
MCT diets vs those receiving LCT diets. All of these factors could
contribute to increased concentrations of TG in the plasma.
The importance of SCFA in the nutriture of the colonic mucosa
has alr�ady been established. Furthermore, SCFA and SCT have
shown clinical significance . . As previously mentioned, their use has
been associated with a reversal of symptoms in diversion colitis in
humans (17), increased intestinal adaptation in rats with short-bowel
syndrome (18), and increased healing of anastamosis in rats (19).
Future research needs to focus on the effects on longer-term oral
diets with SCT in these as well as other intestinal defects.
In summary, providing a diet with 28.5% of its total energy as
the SCT triacetin increases cell number in the jejunum and colon of
rats without any adverse effects on plasma substrate concentrations.
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Part 2: Triacetin feeding for 30 days decreased adipocyte diameter
without adversely affecting growth and development

ABSTRACT

This study determined the effects of a 30 day feeding of either
the short-chain triglyceride triacetin (SCT) or long-chain triglyceride
(LCT) on growth and development, carcass composition, and adipose
tissue cellularity in rats. Male Sprague Dawley rats were given one of
three diets, a control diet containing 5% fat (by calories) or one of
two experimental diets that were 30% fat (by calories). _ _!he source
of the fat calories in the experimental groups was 100% LCT (LCT
group) or 95% SCT/5% LCT (SCT group). Caloric consumption was
higher in the LCT and SCT groups compared to the control group
during weeks 1 and 2. During weeks 3 and 4, the animals in the LCT
group consumed more calories than those in the control group. There
were no significant differences in caloric intake between the LCT and
SCT groups throughout the study. There were no significant
differences in body weight at the onset of the study; hoyvever, the
LCT group weighed significantly more than the other two groups at
the end of the study. In all three fat pads, the SCT group had a
significantly lower pad mass compared to the LCT group. Mean fat
cell size was smaller in all fat depots of animals fed SCT. Perirenal fat
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cell number was significantly lower in the LCT and SCT groups
compared to the control group. Cell number in the other fat pads
(epididymal and inguinal) was not significantly affected by diet. The
% water, % lipid, and % protein in the eviscerated carcass was not
significantly different among groups. Average daily caloric
consumption was not significantly different between the LCT and SCT
groups. Provision of 28.5% of the total calories as SCT during a 30
day feeding resulted in no overt adverse affects while decreasing
adipocyte size in three fat depots and adipocyte number in the
perirenal pad compared to the control group. These changes in
adipocyte cellularity were present without significant changes in total
carcass lipid content.
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I NTRODUCTION

As shown in Part 1, the SCT, triacetin, has trophic effects on
the jejunum and colon of rats. Because of this trophic effect, recent
research has focused on the use of SCFA and SCT in the treatment of
certain intestinal disorders ( 1, 2, 3,4). Thus, SCT have a potential
role as an oral, enteral, and parenteral nutrient. However, little
evidence exists regarding the effects of feeding SCFA or SCT on
whole animal nutriture and carcass composition.
Adipocyte cell size and cell number as well as total fat depot
mass must be considered to determine the effects of diet on total
body adiposity. Cell number has been found to increase during the
life span up to a certain age in rats (5). After adulthood, increases in
adipose tissue cellularity have been found to increase with overfeeding
(6) and high-fat feeding in rats ( 14, 7) especially in the perirenal
depot, which has been found to be particularly plastic with regards to
cell number (8,9). The exact mechanisms for increases in
cellularity of adipose tissue are now known. It has· been suggested
that adipocyte hypertrophy results in the adipocyte reaching a "critical
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fullness" which then stimulates new adipoblasts for filling with lipid
(14). It has been suggested that this process may take place in
humans (10). Adipocyte cell size is influenced by species, age,
diet, and physical activity (11). Bjorntorp suggests that changes in
total fat depot mass and cell size are influenced by genetic factors and
environmental factors (15). Genetic factors include species and
gender. Two primary environmental factors include adipocyte
lipoprotein lipase (LPL) activity and corticosteroids. LPL activity
influences the amount of triglyceride that is taken up by the fat depot
which in turn influences the size of the adipocytes.
A limited number of studies have been carried out using the
SCT triacetin as a starch substitute. Animals fed diets containing up
to 77 %_ SCT (by calories) for up to 26 weeks grew poorly compared
to animals fed control diets (1 2,13,14). Other evidence exists
that providing a diet of 49 % SCT (by calories) for 20 days results in
decreased but not significant differences in growth compared to
control animals (15). At high levels of SCT feeding, growth was
depressed; whereas, at lower levels, weight gain was lower but not to
a significant effe�t. These studies reported using very high levels of
lipid in the diet. A better use of SCT in studies such as these would
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be incorporating SCT into diets at nutritionally appropriate levels.
Because SCT may be an important nutrient in certain digestive
diseases, it is necessary to determine the effects of its long-term use
of growth and development and on body composition. Therefore, the
present study was carried out to determine the effects of a 30 day
feeding of a SCT diet on growth and development, carcass
composition, and adipocyte cell size and number in rats.
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MATERIALS AND METHODS

Animal care and feeding of diets was conducted as previously
stated in Part 1. On day 30, animals were euthanized by
decapitation.
Carcasses were eviscerated and frozen. Carcasses were
ground and mixed with a blender by adding equivalent weights of
water. Aliquots were removed and lyophilized for determination of
percent moisture. A moisture free sample was removed and percent
lipid was determined using a modified soxhlet method (16) .
Percent protein was determined using the Kjeldahl method (17).
Another sample of the dried carcass was burned in a muffle furnace at
550 ° C for percent ash determination (18).
Three adipose tissue depots, epididymal, inguinal, and perirenal,
were dissected as previously described (13) for analysis of cell size
and cell number. A 30-40 mg segment from each pad was incubated
in 2 ml of 0.05 mol/L collidine-HCI buffer, pH 7 .4, plus 3 ml of 2030 g/L osmium tetroxide (Electron Microscopy Sciences, Fort
Washington, PA) in collidine buffer (19). Tissue -samples were
incubated at 37 ° C for 24 hours followed by another 48 hours at
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room temperature. Adipocytes were separated by filtering through a
275 µm screen followed by a 25 µm screen (Tetko, Lancaster, NH).
The first screen filtered out large debris while the second screen
collected the adipocytes. Therefore, all cells between 25 and 275 µm
were used for further analysis. The cells were washed off the screen
with 0. 154 mol/L NaCl into a preweighed beaker to a total weight of
220 g. Triton X-100 (octyl-phenoxy polyethoxyethanol, Sigma, St.
Louis, MO) was added to the saline at 0. 1 g/L to prevent cellular
clumping. The adipocytes were analyzed for cell size and cell number
using a Coulter Counter and Coulter Channelyzer 256 (Hialeah, FL).
Cell diameter distributions were calculated for 10 µm intervals
from 20 µm to 110 µm. The percent adipocytes in each interval was
calculated and plotted to give distributions of cell size for each fat
pad. All other data was analyzed using analysis of variance (ANOVA)
with SAS (Statistical Analysis System) to determine significant
differences among groups due to diet. Significance was considered to
be p < 0.05. If the effect was determined to be statistically different,
Duncan's Multiple Range Test was used to further evaluate the
differences (20).
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RESULTS

As shown in Part 1, no overt adverse effects of any diet were
observed during the 30 days of experimental study. Table 2 (Part 1)
shows the effect of dietary lipid composition on body mass and food
consumption. Body mass was not significantly different at the
beginning of the study period. However, by day 30, the rats in the
LCT group weighed significantly more than the animals in the control
or SCT groups. And even though there was no significant difference
in food consumption for animals consuming 30% LCT and SCT
throught the study period, the SCT group did consume less food than
the LCT group during weeks 3 and 4.
The effects of dietary lipid composition on carcass composition
are shown in Table 1. There were no significant differences in %
water, % lipid, and % protein among groups. The only significant
difference in carcass composition was seen in o/o ash. Carcasses in
the control group were significantly higher in % ash than those in the
LCT and SCT groups.
Total fat depot mass was affected by diet as shown in Table 2 .
In the epididymal fat pad, the animals consuming the LCT diet had the
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Table 1 . Carcass composition of rats fed short- or long-chain
triglyceride for 30 days
Group

% water

% lipid

Control

54.8 ± 0 .94

32 . 1 ± 1 .86

8.93

LCT

54.6 ± 1 .03

SCT

53 . 1 ± 2 .25

% protein

% ash

±

0.37

9 . 9 1 ± 1 .44

33.6 ± 4.4 1

8.62 ± 0.67

8.55 ± 0 . 5 5

30.3 ± 4.44

8.29 ± 0.58

8 . 6 7 ± 1 .0 1

� animals per group; values expressed as means ± SEM
significantly different from other groups, p < 0.05
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Table 2. Epididymal, inguinal, and perirenal fat depot mass of rats fed
short- or long-chain triglyceride for 30 days
Mass
(g )

Group

Control

3.04 ± 0. 1 8

LCT

4.00 ± 0.22

SCT

2 . 97 ± 0. 1 3

Peri renal

Inguinal

Epididymal
•

5 .37 ± 0 . 29

3 .04 ± 0.25

6.08 ± 0.40

3 . 73 ± 0 .37

••

4.61 ± 0. 1 4

� animals per group; all values expressed as means ± SEM
· ••significantly different from other groups, p < 0 .05
significantly different from SCT
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••

2.59 ± 0.20

pad with the greatest ·mass. It's mass was 24% greater than the
mass of the pad in the control group and 26% greater than the mass
of the pad in the SCT group. In the inguinal fat pad, the SCT group
had a pad mass that was 24% lower than that of the LCT group. The
only difference in pad mass in the perirenal pad was between the SCT
and LCT groups. The pad mass of the animals consuming the SCT
diet was signficiantly lower (31%) than the pad mass of those
consuming the LCT diet.
Adipocyte size distributions for epididymal, inguinal, and
perirenal fat pads are shown in Figures 1, 2, and 3 respectively. In
the epididymal fat depot (Figure 1), it is evident that SCT feeding
decreased adipocyte size. All distributions appear monophasic with
the con�rol group peaking between 65 -75 µm, the LCT group peaking
around 75 µm, and the SCT group peaking between 35-45 µm. The
mean cell size yvas also significantly affected by diet. The SCT group
had a significantly lower (p < 0.05) mean cell size (51 .4 ± 0. 6 µm)
compared to the control group (70. 3 ± 1.0 µm) and LCT group (74.1
± 1. 8 µm). In the inguinal fat depot (Figure 2), SCT feeding also
resulted in smaller adipocytes. The mean cell size in the SCT group
(53. 6 ± 1.8 µm) was significantly lower (p < 0.05) than the mean
56
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Figure 1 . Adipocyte size distribution in the epididymal fat depot of rats
fed short- or long-chain triglyceride for 30 days
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Figure 2. Adipocyte size distribution in the inguinal fat depot of rats
fed short- or long-chain triglyceride for 30 days
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Figure 3 . Adipocyte size distribution in the perirenal fat depot of rats
fed short- or long-chain triglyceride for 30 days
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cell size in the control group (61. 7 ± 2.0 pm) and the LCT group
(53. 6 ± 2.0 pm). The adipocyte distribution in the SCT group also
shows smaller cells with it peaking between 35-45 pm. LCT feeding
resulted in a biphasic distribution with two peaks around 25 pm and
65-75 pm. The adipocyte distribution peaking between 65-75 pm.
The distributions for adipocyte diameter in the perirenal fat depot are
similar to those seen in the inguinal depot. SCT feeding once again
resulted in smaller adipocytes. The mean cell size in the SCT group
(55.5 ± 0. 9 pm) was significantly smaller compared to the control
group (70.4 ± 1.2 pm) and the LCT group (72.0 ± 1. 3 pm). The
adipocyte diameter distribution in the LCT group is biphasic with
peaks around 25 pm and 85-95 pm. The adipocyte diameters in the
control_group peak between 75-85 pm. In the SCT group, the
distribution is monophasic with a peak in cell diameter between 35-45
pm.
Total adipocyte number for the epididymal, inguinal, and
perirenal fat pads are shown in Table 3. Cell number in the epididymal
and inguinal fat pads were unaffected by diet. However, in the
perirenal pad, th� LCT and SCT groups had a significantly reduced cell
number compared to the control group.
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Table 3. Epididymal, inguinal, and perirenal fat cell number of rats fed
short- or long-chain triglyceride for 30 days
•
Cell Number
Group

Epididymal

Inguinal

Peri renal

••

Control

30.98 ± 2 . 84

58.74 ± 5 . 97

LCT

27 .20 ± 1 . 85

49.70 ± 5 .50

22.76 ± 2.05

SCT

36 .03 ± 3 .06

66.48 ± 6. 1 4

23 .49 ± 2 . 1 4

� animals per group; all values expressed as means ± SEM
8
• •means X 1 0
significantly different from other groups, p < 0.05
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29.47 ± 1 .57

DISCUSSI ON

Supplying SCT to the diet of rats at 28.5 % of total calories did
inhibit growth and development somewhat; however, the difference
was not statistically significant extent, as discussed in Part 1. These
results are in agreement with McAtee et al. (20) but do not support
other results of high fat SCT feedings (12- 15).
Overall, carcass composition was unaffected by dietary lipid
composition. Percent water, lipid, aQd protein were not significantly
different among groups. As this is the first known documented study
of the effect of SCT feeding on carcass composition, these results can
only be compared to carcass composition from the feeding of other
lipid constituents. Results of a study by Turkenkopf et al. indicate
that medium-chain triglyceride (MCT) and LCT feeding at 65 % of
calories did not alter % nonlipid in eviscerated carcasses of lean and
obese Zucker rats while MCT feeding in lean Zucker rats lowered %
lipid compared to control animals (2 1).
In all three fat depots, the. animals consuming 30% LCT had
significantly greater fat pad mass compared to animals consuming the
SCT diet. These results reflect the differences in mean adipocyte
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diameter as the SCT group had significantly smaller adipocytes in all
three fat depots. Even though the LCT group consumed more Kcal/d
during weeks 3 and 4, the difference was not significant. And during
weeks 1 and 2, the caloric intakes of the LCT and SCT groups was
al most identical . Th is leads to the question if the SCT diet was less
energy efficient than the LCT diet. As alterations in adipose tissue
LPL activity can lead to changes in cell size , cell number, and depot
mass ( 1 1 ) , decreased adipocyte LPL activity in the SCT group could
be contributing to the decrease seen in depot mass. With high-fat
MCT feedings, LPL activity ..was lower in the adipocytes of obese
Zucker rats compared to controls ( 1 ) .
Adipocyte cell size distri butions were determined from 20 µm to
1 1 0 µm. Cells below 20 µm may not be adipocytes . Adipose tissue
contains adipocytes, blood cells, endothelial cells, pericytes,
fibroblasts, and small fat cells, which some investigators have called
prea�ipocytes. Of all these cells, 33-67 % are adipocytes ( 1 5 ) .
Adipocytes and preadipocytes have been differentiated b y size with
adipocytes being

> 20 µm and preadipocytes being < 20 µm ( 1 0) .

Therefore, in order to ensure the measurement of only adipocytes, a
lower limit of 20 µm was used .
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Epididymal adipocyte distributions were monophasic for all
dietary treatments. But in the inguinal and perirenal fat depots, the
distributions were biphasic in the LCT group, meaning that in these
depots there were small and large adipocytes. Biphasic distributions
in the adipose tissue of rabbits (22) and rats (23, 16) have been
documented in epididymal, inguinal, and perirenal depots. However,
changes in distributions of adipocyte diameter were noted with aging
and dietary restriction (1 6).
The total cell number in the epididymal and inguinal fat depots
was unaffected by diet. This was not the case in the perirenal fat
pad. In this depot, 30% LCT �nd SCT feeding resulted in a significant
reduction in the number of adipocytes present. Of the fat depots
studied �n this study, the perirenal depot has been found to be the
latest maturing and most dynamic depot (13). Perirenal cell number
has been founct to increase with aging (14). In the present study, the
increases in cell number in the perirenal depot that occur with aging
were decreased with increased dietary lipid. These results conflict
with the results of other studies which report increases in cell number
with high-fat feeding (12).
In summary, SCT have some potential clinical advantages. SCT
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are water soluble and can be easily mixed into water-based parenteral
formulations, have a trophic effect on the intestinal epithelium and
may be useful in the treatment of certain intestinal diseases. Because
of the potential use of SCT as a clinical nutrient, it is necessary to
determine the effects of SCT feeding on growth and development and
body composition. The results of the present study indicate that SCT
feeding for 30 days resulted in decreased mean adipocyte size in the
epididymal, inguinal, and perirenal depots with concomitant decreases
in total depot mass and body mass. These affects were achieved
without significantly affecting carcass composition or caloric
consumption.
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